LOS ANGELES, March 04, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented the poster “Suppressing Asymptomatic CMV with ...
The novel vaccine, known as VIR-1388, uses a weaker version of cytomegalovirus, or CMV, to deliver the HIV vaccine materials to a patient’s immune system. Researchers hope that this method of vaccine ...
Recent $11.3 million grant from the California Institute for Regenerative Medicine (CIRM) intended to fund the Phase 1 clinical trial at City of Hope; the Investigational New Drug application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback